Chronic myeloid leukaemia (CML) is a haematopoietic stem cell malignancy characterized by the t(9;22) chromosomal translocation that generates the BCR/ABL oncogene 1, 2. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.